We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $109M
1-Year Est. Return 97.13%
This Fund
S&P 500
This Quarter Est. Return
+34.11%
1 Year Est. Return
+97.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
+$6.53M
Cap. Flow
-$6.26M
Cap. Flow %
-5.72%
Top 10 Hldgs %
32.08%
Holding
212
New
75
Increased
28
Reduced
43
Closed
29

Top Buys

Rank Stock Value
1
NOMD icon
Nomad Foods
NOMD
+$1.34M
2
MLAA
Mountain Lake Acquisition Corp II
MLAA
+$1.27M
3
DSGR icon
Distribution Solutions Group
DSGR
+$1.26M
4
ENGN icon
enGene Therapeutics
ENGN
+$1.24M
5
ABVX
Abivax
ABVX
+$1.02M

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$8.47M
2
LEG
Leggett & Platt
LEG
+$2.1M
3
ICLR icon
Icon
ICLR
+$1.96M
4
KZR
Kezar Life Sciences
KZR
+$1.8M
5
MCW
Mister Car Wash
MCW
+$1.54M

Sector Composition

Rank Sector Weight
1 Healthcare 27.11%
2 Consumer Discretionary 14.33%
3 Financials 12.51%
4 Miscellaneous 10.11%
5 Real Estate 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KROS icon
51
Keros Therapeutics
KROS
$221M
$582K 0.53%
54,400
– –
HEPS
52
D-Market Electronic Services & Trading
HEPS
$940M
$582K 0.53%
200,000
– –
META icon
53
CALL
Meta Platforms (Facebook)
META
$1.66T
$563K 0.51%
+1,000
New +$611K
CORZW icon
54
Core Scientific Inc Tranche 1 Warrants
CORZW
$1.13B
$553K 0.51%
21,600
-5,600
-21% -$94.3K
ENGN icon
55
enGene Therapeutics
ENGN
$121M
$528K 0.48%
+305,102
New +$1.24M
IBIT icon
56
CALL
iShares Bitcoin Trust
IBIT
$60.4B
$526K 0.48%
+15,800
New +$643K
SSP icon
57
E.W. Scripps
SSP
$289M
$518K 0.47%
187,000
+101,510
+119% +$384K
GPACU
58
General Purpose Acquisition Corp Units
GPACU
$505K 0.46%
50,000
– –
NKTR icon
59
Nektar Therapeutics
NKTR
$2.39B
$489K 0.45%
+7,000
New +$512K
KVYO icon
60
Klaviyo
KVYO
$4.54B
$468K 0.43%
+31,000
New +$514K
SVAQ
61
Silicon Valley Acquisition Corp
SVAQ
$295M
$466K 0.43%
+46,162
New +$461K
QURE icon
62
uniQure
QURE
$3.09B
$461K 0.42%
10,000
-3,000
-23% -$78.5K
FCRS
63
FutureCrest Acquisition Corp
FCRS
$368M
$454K 0.41%
44,070
+3,367
+8% +$34.3K
IBIT icon
64
iShares Bitcoin Trust
IBIT
$60.4B
$453K 0.41%
+13,600
New +$553K
ALNY icon
65
Alnylam Pharmaceuticals
ALNY
$33.9B
$452K 0.41%
+1,500
New +$452K
IKT icon
66
Inhibikase Therapeutics
IKT
$328M
$447K 0.41%
220,000
– –
ACET icon
67
Adicet Bio
ACET
$90.2M
$440K 0.4%
50,892
-5,108
-9% -$40.3K
OKUR
68
OnKure Therapeutics
OKUR
$127M
$433K 0.4%
95,000
– –
OACC
69
Oaktree Acquisition Corp III Life Sciences
OACC
$265M
$431K 0.39%
40,239
-20,949
-34% -$223K
GTERU
70
Globa Terra Acquisition Corp Units
GTERU
$159M
$422K 0.39%
40,361
– –
FULC icon
71
Fulcrum Therapeutics
FULC
$291M
$420K 0.38%
+114,890
New +$699K
NWAX.U
72
New America Acquisition I Corp Units
NWAX.U
$414K 0.38%
40,000
– –
CRBP icon
73
Corbus Pharmaceuticals
CRBP
$155M
$413K 0.38%
44,000
-840
-2% -$7.95K
ARQ icon
74
Arq
ARQ
$97.4M
$400K 0.37%
+157,000
New +$390K
LXU icon
75
LSB Industries
LXU
$839M
$378K 0.35%
+35,000
New +$468K
1 2
3
4 5

Similar funds

GCM
Gumshoe Capital Management New York $109M AUM
SSCM
Seven Six Capital Management New York $110M AUM 1.79% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $110M AUM
BWM
Briggs Wealth Management Glastonbury, Connecticut $110M AUM
QFMHK
Q Fund Management (Hong Kong) Hong Kong $110M AUM 1,372.85% 1-Year Est. Return
AC
Amitell Capital Singapore $109M AUM 50.64% 1-Year Est. Return
ANBOT
American National Bank of Texas Richardson, Texas $110M AUM 17.16% 1-Year Est. Return
SCA
Sensenig Capital Advisors Collegeville, Pennsylvania $109M AUM

Rangeley Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Rangeley Capital held 212 positions worth $109M, up 6.3% from $103M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Rangeley Capital withdrew a net $6.26M in Q2 2026, closing 29 positions and reducing 43 holdings. Its most notable exit was Leggett & Platt, an estimated $2.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Rangeley Capital opened a new position in Nomad Foods worth $1.48M.

  • Rangeley Capital's largest Q2 2026 buy was Nomad Foods: 135,000 shares worth $1.48M.
  • Rangeley Capital added most to Distribution Solutions Group in Q2 2026, an estimated $1.26M increase.
  • Rangeley Capital's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $8.47M.
  • Rangeley Capital fully exited Leggett & Platt in Q2 2026, selling an estimated $2.1M.
  • Rangeley Capital's ten largest holdings make up 32% of its $109M portfolio in Q2 2026.
  • Rangeley Capital opened 75 new positions and closed 29 in Q2 2026.
  • Rangeley Capital's portfolio value rose 6.3% quarter-over-quarter to $109M.

Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.